BPC-157 and TB-500 (Ac-LKKTETQ) Interaction

Synergistic
Researched 95% confidence

BPC-157 and TB-500 (Ac-LKKTETQ) have a synergistic interaction with 95% confidence. Commonly combined for enhanced healing effects through different mechanisms. Both compounds affect the blood vessels, so monitoring these systems is recommended.

Compound Profiles

BPC-157

Body Protection Compound-157 | Pentadecapeptide

Promotes blood vessel formation (angiogenesis), enhances collagen synthesis, modulates growth factor expression including VEGF, and protects against tissue damage through localized or systemic delivery pathways..

Half-life: <30 minutes Typical dose: 250-500mcg healing, longevity
vegf anticoagulantcarcinogenic riskpro angiogenicteratogenic
View full profile

TB-500 (Ac-LKKTETQ)

Thymosin Beta-4 Active Fragment | Healing Peptide

TB-500 contains the LKKTETQ sequence which is the actin-binding motif of full-length thymosin beta-4. This fragment shares many properties of the parent protein regarding cell proliferation, differentiation, and migration.

Half-life: Not precisely established; effects persist longer than 24 hours Typical dose: 2-2.5mg per injection healing, longevity
vegf teratogenic
View full profile

Combined Organ Load

Blood Vessels
low

Shared Safety Flags

2x 2 compounds share the teratogenic safety flag (BPC-157, TB-500 (Ac-LKKTETQ)). Monitor accordingly.

Frequently Asked Questions

Can I take BPC-157 with TB-500 (Ac-LKKTETQ)?

Yes, BPC-157 and TB-500 (Ac-LKKTETQ) can generally be taken together. Commonly combined for enhanced healing effects through different mechanisms.

Is BPC-157 and TB-500 (Ac-LKKTETQ) safe together?

Based on documented research, this combination is considered synergistic. However, shared safety flags include: teratogenic. Monitor accordingly.

What are the interactions between BPC-157 and TB-500 (Ac-LKKTETQ)?

Commonly combined for enhanced healing effects through different mechanisms. This assessment has 95% confidence and is based on documented research data.

How should I time BPC-157 and TB-500 (Ac-LKKTETQ)?

BPC-157 has a half-life of <30 minutes and TB-500 (Ac-LKKTETQ) has a half-life of Not precisely established; effects persist longer than 24 hours. No specific timing requirements identified for this combination, but separating administration can help monitor individual effects.

Check this pair in the full Interaction Checker Full comparison: BPC-157 vs TB-500 (Ac-LKKTETQ)

This interaction analysis is compiled from research literature and pharmacological mechanism data. Always consult a healthcare professional before combining compounds.